Alperen Akansel Çağlar

ORCID: 0000-0001-8541-3418
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gastric Cancer Management and Outcomes
  • Inflammatory Biomarkers in Disease Prognosis
  • Endometrial and Cervical Cancer Treatments
  • Ovarian cancer diagnosis and treatment
  • Helicobacter pylori-related gastroenterology studies
  • Adipose Tissue and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Esophageal Cancer Research and Treatment
  • Cytokine Signaling Pathways and Interactions
  • Lung Cancer Treatments and Mutations
  • Liver Disease Diagnosis and Treatment
  • Mitochondrial Function and Pathology
  • Pituitary Gland Disorders and Treatments
  • Cancer Immunotherapy and Biomarkers
  • Growth Hormone and Insulin-like Growth Factors

Atatürk University
2024-2025

Erzurum Regional Training and Research Hospital
2020

Aim: Cancer is a major cause of death. Globocan data shows 20 million new cancer cases and 9.7 deaths year. Lung the most common globally, followed by breast, colorectal, prostate stomach cancers. types vary age, gender, race, region. Documenting regional crucial for screening, early diagnosis, treatment cancers, as well understanding underlying causes. Despite high incidence upper gastrointestinal (GI) cancers in eastern Türkiye, there little documented evidence on specific these regions....

10.37990/medr.1572275 article EN Medical Records 2025-01-10

Abstract Background Cervical cancer is a tumor with high morbidity and mortality. The importance of inflammatory metabolic parameters affecting progression-free survival (PFS) overall (OS) has been investigated more intensively recently. We aimed to investigate the effect glucose/c-reactive protein (CRP) ratio [GCR], which shows these two together, on PFS in cervical cancer. Methods retrospectively included 90 patients adenocarcinoma squamous cell carcinoma cervix. effects clinical...

10.1186/s12885-024-12347-x article EN cc-by BMC Cancer 2024-05-23

Aim: The tumor microenvironment of NSCLC with driver mutations, such as EGFR, ALK and ROS, is less inflammatory. Materials & methods: This retrospective study included 38 patients mutations. relationship between clinical inflammatory markers concerning progression-free survival overall was analyzed based on Kaplan-Meier curves. Results: mean age the 59.8 ± 11.9. Progression-free were significantly longer in under 65 years low neutrophil–lymphocyte ratio, systemic immune-inflammation index...

10.2217/lmt-2023-0014 article EN Lung Cancer Management 2024-02-28

Amaç: Mide kanseri tüm dünyada ki yeni kanser vakalarının %5,6’sını oluşturur ve beşinci en sık görülen türüdür. Kansere bağlı ölüm sıralamasında ise üçüncü sırada yer almaktadır. Lokalileri mide kanserinde, günümüzde standart neoadjuvan tedavi ile hastaların yalaşık % 75’ine uygun rezeksiyon yapılabilmektedir. Hastaların iki yıllık hayatta kalma oranları yaklaşık %70 iken bu oran yılda %45’lere düşmektedir. Bir çok türünde erken tanı yüksek küratif uzun süreli sağkalım başarısı sağlanmasına...

10.18663/tjcl.1442369 article TR Turkish Journal of Clinics and Laboratory 2024-08-16

Aim: Patients with acromegaly are at risk of metabolic diseases, such as diabetes mellitus, insulin resistance and hypertriglyceridemia. We aimed to investigate what is effective in the development non-alcoholic fatty liver disease (NAFLD) patients acromegaly.Materials Methods: 60 (33 female, 27 male) acromegaly, a healthy control group 52 persons (27 female 25 were retrospectively studied. Mean age 44.11 ±13.83 39.12±14.99 respectively. Body mass index (BMI), ultrasound laboratory findings...

10.18663/tjcl.604304 article EN Turkish Journal of Clinics and Laboratory 2020-02-10
Coming Soon ...